The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Recommended - Individuals: transactions
With a sweeping reach across Europe, Taylor Wessing also benefits from strong local expertise, with practitioners on deck with the technical acumen and legal sagacity to skilfully handle high-stakes contentious and non-contentious instructions. The team earns praise for being “hardworking, responsive, client-focused and offering extremely high-quality advice”. Heading up the international patents and UK life sciences groups, the “practical and knowledgeable” Simon Cohen is a formidable adversary in big-ticket litigation. He puts together logical, bulletproof arguments and seamlessly coordinates strategy across jurisdictions for some of the best life sciences companies on the market. Captaining the UK patent team, Nigel Stoate is a “strong and experienced patent litigator”. He puts in sophisticated performances in hotly contested disputes and has a glittering track record of success. Likewise, Matthew Royle is admired for his “strong expertise”. His well-rounded advice and instinct for the best arguments means he executes litigation strategies with calmness and finesse. “Christopher Thornham is one of the most creative and energetic patent litigators practising right now in the UK. His ability to look at a case and find the best strategic approach is unparalleled, and the breadth of network that he demonstrates can be incredibly useful in finding the right solution for the right problem. Backed up by a formidable intellect, Chris is a go-to attorney for difficult cases.” On the non-contentious side Colin McCall is a leading life sciences licensing expert who harnesses more than two decades of experience to identify and exploit commercialisation opportunities for his patrons. He is thorough in his approach and uncompromising on quality, making him a go-to for high-value, patent-intensive deals. Recently he has been advising Thermax on its exclusive licensing agreement with Radius Health, for the rights to commercialise abaloparatide, a medication used to manage and treat osteoporosis. IAM Patent 1000 newcomer Adrian Toutoungi has a focus on building and nurturing long-term client relationships. He immerses himself in their industries to gain a well-rounded understanding of their needs and the factors affecting their business, to provide the most commercially relevant advice possible. He advises a number of universities and spin-outs, including Salience Labs, a joint spin-out of Oxford and Munster Universities, on IP licensing agreements.